Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 56

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Gut bacterial deamination of residual levodopa medication for Parkinson’s disease

van Kessel, Sebastiaan P., de Jong, Hiltje R., Winkel, Simon L., van Leeuwen, Sander S., Nelemans, Sieger A., Permentier, Hjalmar, Keshavarzian, Ali, El Aidy, Sahar·2020·BMC Biology
DOI 10.1186/s12915-020-00876-3

Published version of a preprint

Open this paper in CoChat — free account

Abstract

Background: Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by both motor and non-motor symptoms. Gastrointestinal tract dysfunction is one of the non-motor features, where constipation is reported as the most common gastrointestinal symptom. Aromatic bacterial metabolites are attracting considerable attention due to their impact on gut homeostasis and host’s physiology. In particular, Clostridium sporogenes is a key contributor to the production of these bioactive metabolites in the human gut. Results: Here, we show that C. sporogenes deaminates levodopa, the main treatment in Parkinson’s disease, and identify the aromatic aminotransferase responsible for the initiation of the deamination pathway. The deaminated metabolite from levodopa, 3-(3,4-dihydroxyphenyl)propionic acid, elicits an inhibitory effect on ileal motility in an ex vivo model. We detected 3-(3,4-dihydroxyphenyl)propionic acid in fecal samples of Parkinson’s disease patients on levodopa medication and found that this metabolite is actively produced by the gut microbiota in those stool samples. Conclusions: Levodopa is deaminated by the gut bacterium C. sporogenes producing a metabolite that inhibits ileal motility ex vivo. Overall, this study underpins the importance of the metabolic pathways of the gut microbiome involved in drug metabolism not only to preserve drug effectiveness, but also to avoid potential side effects of bacterial breakdown products of the unabsorbed residue of medication.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12915-020-00876-3

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 38

  1. Donia MS, Fischbach MA. Small molecules from the human microbiota. Science. 2015;349:1254766. https://doi.org/10.1126/science.1254766. · DOI · Paper page
  2. Bansal T, Alaniz RC, Wood TK, Jayaraman A. The bacterial signal indole increases epithelial-cell tight-junction resistance and attenuates indicators of inflammation. Proc Natl Acad Sci. 2010;107:228–33. https://doi.org/10.1073/pnas.0906112107. · DOI · Paper page
  3. Schiering C, Wincent E, Metidji A, Iseppon A, Li Y, Potocnik AJ, et al. Feedback control of AHR signalling regulates intestinal immunity. Nature. 2017;542:242–5. https://doi.org/10.1038/nature21080. · DOI
  4. Yano JM, Yu K, Mazmanian SK, Hsiao Correspondence EY, Donaldson GP, Shastri GG, et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell. 2015;161:264–76. https://doi.org/10.1016/j.cell.2015.02.047. · DOI · Paper page
  5. Bhattarai Y, Williams BB, Battaglioli EJ, Whitaker WR, Till L, Grover M, et al. Gut microbiota-produced tryptamine activates an epithelial G-protein-coupled receptor to increase colonic secretion. Cell Host Microbe. 2018;23:775–85.e5. https://doi.org/10.1016/j.chom.2018.05.004. · DOI · Paper page
  6. Venkatesh M, Mukherjee S, Wang H, Li H, Sun K, Benechet AP, et al. Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and toll-like receptor 4. Immunity. 2014;41:296–310. https://doi.org/10.1016/j.immuni.2014.06.014. · DOI · Paper page
  7. Barker HA. Amino acid degradation by anaerobic bacteria. Annu Rev Biochem. 1981;50:23–40. https://doi.org/10.1146/annurev.bi.50.070181.000323. · DOI
  8. Yvon M, Thirouin S, Rijnen L, Fromentier D, Gripon J. An aminotransferase from Lactococcus lactis initiates conversion of amino acids to cheese flavor compounds. Appl Envir Microbiol. 1997;63:414–9. https://doi.org/10.1128/AEM.63.2.414-419.1997. · DOI · Paper page
  9. Nierop Groot MN, De Bont JAM. Conversion of phenylalanine to benzaldehyde initiated by an aminotransferase in Lactobacillus plantarum. Appl Environ Microbiol. 1998;64:3009–13. https://doi.org/10.1128/AEM.64.8.3009-3013.1998. · DOI
  10. Dickert S, Pierik AJ, Linder D, Buckel W. The involvement of coenzyme A esters in the dehydration of (R)-phenyllactate to (E)-cinnamate by Clostridium sporogenes. Eur J Biochem. 2000;267:3874–84. https://doi.org/10.1046/j.1432-1327.2000.01427.x. · DOI
  11. Bianchine JR, Messiha FS, Hsu TH. Peripheral aromatic L-amino acids decarboxylase inhibitor in parkinsonism. II. Effect on metabolism of L-2- 14 C-dopa. Clin Pharmacol Ther. 1972;13:584–94. https://doi.org/10.1002/cpt1972134584. · DOI
  12. Morgan JP. Metabolism of levodopa in patients with Parkinson’s disease. Arch Neurol. 1971;25:39. https://doi.org/10.1001/archneur.1971.00490010049007. · DOI
  13. Sasahara K, Nitanai T, Habara T, Kojima T, Kawahara Y, Morioka T, et al. Dosage form design for improvement of bioavailability of levodopa IV: possible causes of low bioavailability of oral levodopa in dogs. J Pharm Sci. 1981;70:730–3. https://doi.org/10.1002/jps.2600700705. · DOI
  14. Goldin BR, Peppercorn MA, Goldman P. Contributions of host and intestinal microflora in the metabolism of L-dopa by the rat. J Pharmacol Exp Ther. 1973;186:160–6.
  15. Fasano A, Visanji NP, Liu LWC, Lang AE, Pfeiffer RF. Gastrointestinal dysfunction in Parkinson’s disease. Lancet Neurol. 2015;14:625–39. https://doi.org/10.1016/S1474-4422(15)00007-1. · DOI · Paper page
  16. Panagamuwa B, Kumar D, Ortiz J, Keighley MRB. Motor abnormalities in the terminal ileum of patients with chronic idiopathic constipation. Br J Surg. 1994;81:1685–8. https://doi.org/10.1002/bjs.1800811142. · DOI
  17. Van Der Sijp JRM, Kamm MA, Nightingale JMD, Britton KE, Granowska M, Mather SJ, et al. Disturbed gastric and small bowel transit in severe idiopathic constipation. Dig Dis Sci. 1993;38:837–44. https://doi.org/10.1007/BF01295909. · DOI
  18. Dutkiewicz J, Szlufik S, Nieciecki M, Charzyńska I, Królicki L, Smektała P, et al. Small intestine dysfunction in Parkinson’s disease. J Neural Transm. 2015;122:1659–61. https://doi.org/10.1007/s00702-015-1442-0. · DOI
  19. Knudsen K, Haase AM, Fedorova TD, Bekker AC, Ostergaard K, Krogh K, et al. Gastrointestinal transit time in Parkinson’s disease using a magnetic tracking system. J Parkinsons Dis. 2017;7:471–9. https://doi.org/10.3233/JPD-171131. · DOI
  20. Das YT, Bagchi M, Bagchi D, Preuss HG. Safety of 5-hydroxy-L-tryptophan. Toxicol Lett. 2004;150:111–22. https://doi.org/10.1016/j.toxlet.2003.12.070. · DOI
  21. Heap JT, Kuehne SA, Ehsaan M, Cartman ST, Cooksley CM, Scott JC, et al. The ClosTron: mutagenesis in Clostridium refined and streamlined. J Microbiol Methods. 2010;80:49–55. https://doi.org/10.1016/j.mimet.2009.10.018. · DOI · Paper page
  22. Roager HM, Hansen LBS, Bahl MI, Frandsen HL, Carvalho V, Gøbel RJ, et al. Colonic transit time is related to bacterial metabolism and mucosal turnover in the gut. Nat Microbiol. 2016;1:16093. https://doi.org/10.1038/nmicrobiol.2016.93. · DOI · Paper page
  23. Iwamoto K, Watanabe J, Yamada M, Atsumi F, Matsushita T. Effect of age on gastrointestinal and hepatic first-pass effects of levodopa in rats. J Pharm Pharmacol. 1987;39:421–5. https://doi.org/10.1111/j.2042-7158.1987.tb03413.x. · DOI
  24. Zoetendal EG, Raes J, van den Bogert B, Arumugam M, Booijink CC, Troost FJ, et al. The human small intestinal microbiota is driven by rapid uptake and conversion of simple carbohydrates. ISME J. 2012;6:1415–26. https://doi.org/10.1038/ismej.2011.212. · DOI · Paper page
  25. Costa M, Brookes SJ, Hennig GW. Anatomy and physiology of the enteric nervous system. Gut. 2000;47(Suppl 4):iv15–9; discussion iv26. https://doi.org/10.1136/gut.47.suppl_4.iv15. · DOI
  26. Ringdahl B. Dissociation constants and relative efficacies of acetylcholine, (+)- and (-)-methacholine at muscarinic receptors in the guinea-pig ileum. Br J Pharmacol. 1986;89:7–13. https://doi.org/10.1111/j.1476-5381.1986.tb11115.x. · DOI
  27. Jenner AM, Rafter J, Halliwell B. Human fecal water content of phenolics: the extent of colonic exposure to aromatic compounds. Free Radic Biol Med. 2005;38:763–72. https://doi.org/10.1016/j.freeradbiomed.2004.11.020. · DOI · Paper page
  28. Jin JS, Hattori M. Isolation and characterization of a human intestinal bacterium Eggerthella sp. CAT-1 capable of cleaving the C-Ring of (+)-catechin and (-)-Epicatechin, followed by p-dehydroxylation of the B-ring. Biol Pharm Bull. 2012;35:2252–6. · DOI
  29. Kalia VC, Mukherjee T, Bhushan A, Joshi J, Shankar P, Huma N. Analysis of the unexplored features of rrs (16S rDNA) of the genus Clostridium. BMC Genomics. 2011;12. https://doi.org/10.1186/1471-2164-12-18. · DOI
  30. Niehues M, Hensel A. In-vitro interaction of L-dopa with bacterial adhesins of Helicobacter pylori: an explanation for clinicial differences in bioavailability? J Pharm Pharmacol. 2009;61:1303–7. https://doi.org/10.1211/jpp/61.10.0005. · DOI
  31. Zimmermann M, Zimmermann-Kogadeeva M, Wegmann R, Goodman AL. Separating host and microbiome contributions to drug pharmacokinetics and toxicity. Science. 2019;363:eaat9931. https://doi.org/10.1126/science.aat9931. · DOI · Paper page
  32. Williams BB, Van Benschoten AH, Cimermancic P, Donia MS, Zimmermann M, Taketani M, et al. Discovery and characterization of gut microbiota decarboxylases that can produce the neurotransmitter tryptamine. Cell Host Microbe. 2014;16:495–503. https://doi.org/10.1016/j.chom.2014.09.001. · DOI · Paper page
  33. Lucchelli A, Boselli C, Grana E. Dopamine-induced relaxation of the guinea-pig isolated jejunum is not mediated through dopamine receptors. Pharmacol Res. 1990;22:433–44. https://doi.org/10.1016/1043-6618(90)90750-8. · DOI
  34. Heap JT, Pennington OJ, Cartman ST, Carter GP, Minton NP. The ClosTron: a universal gene knock-out system for the genus Clostridium 2007;70:452–464. doi:https://doi.org/10.1016/j.mimet.2007.05.021. · DOI · Paper page
  35. Williams DR, Young DI, Young M. Conjugative plasmid transfer from Escherichia coli to Clostridium acetobutylicum. J Gen Microbiol. 1990;136:819–26. https://doi.org/10.1099/00221287-136-5-819. · DOI
  36. Nagatsu T, Kojima K. Application of electrochemical detection in high-performance liquid chromatography to the assay of biologically active compounds. TrAC Trends Anal Chem. 1988;7:21–7. https://doi.org/10.1016/0165-9936(88)80026-8. · DOI
  37. Wood DE, Lu J, Langmead B. Improved metagenomic analysis with Kraken 2. Genome Biol. 2019;20:1–13. https://doi.org/10.1186/s13059-019-1891-0. · DOI
  38. Lu J, Breitwieser FP, Thielen P, Salzberg SL. Bracken: estimating species abundance in metagenomics data. PeerJ Comput Sci. 2017;2017:1–17. https://doi.org/10.7717/peerj-cs.104. · DOI

Cited by

See all 56

Metadata

Authors
van Kessel, S. P., de Jong, H. R., Winkel, S. L., van Leeuwen, S. S., Nelemans, S. A., Permentier, H., Keshavarzian, A., & El Aidy, S.
Venue
BMC Biology
Publisher
Springer Science and Business Media LLC
Published
2020-10-20
Volume
18
Issue
1
ISSN
1741-7007
DOI
10.1186/s12915-020-00876-3
Cited by
56
References
9
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.